Augmedix, Inc. (NASDAQ: AUGX) Stock Competitors & Peer Comparison
See AUGX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AUGX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AUGX | $2.35 | -0.21% | 115.9M | -4.99 | -$0.47 | N/A |
| VEEV | $195.38 | -1.01% | 31.7B | 23.46 | $8.33 | N/A |
| GEHC | $63.07 | -4.00% | 28.7B | 13.83 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $70.69 | +3.71% | 13.9B | 57.01 | $1.24 | N/A |
| BTSGU | $231.53 | +1.23% | 13.5B | 209.36 | $1.11 | N/A |
| TEM | $52.47 | -2.09% | 9.2B | -104.94 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $97.67 | +2.73% | 8.3B | 23.06 | $4.28 | N/A |
| HNGE | $87.09 | +1.29% | 6.7B | 44.66 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
AUGX vs VEEV Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, VEEV has a market cap of 31.7B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while VEEV trades at $195.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas VEEV's P/E ratio is 23.46. In terms of profitability, AUGX's ROE is -1.55%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, AUGX is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
AUGX vs GEHC Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, GEHC has a market cap of 28.7B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while GEHC trades at $63.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas GEHC's P/E ratio is 13.83. In terms of profitability, AUGX's ROE is -1.55%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, AUGX is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
AUGX vs GEHCV Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas GEHCV's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, AUGX is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
AUGX vs BTSG Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, BTSG has a market cap of 13.9B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while BTSG trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas BTSG's P/E ratio is 57.01. In terms of profitability, AUGX's ROE is -1.55%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, AUGX is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
AUGX vs BTSGU Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, BTSGU has a market cap of 13.5B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while BTSGU trades at $231.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas BTSGU's P/E ratio is 209.36. In terms of profitability, AUGX's ROE is -1.55%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, AUGX is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
AUGX vs TEM Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, TEM has a market cap of 9.2B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while TEM trades at $52.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas TEM's P/E ratio is -104.94. In terms of profitability, AUGX's ROE is -1.55%, compared to TEM's ROE of -0.70%. Regarding short-term risk, AUGX is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
AUGX vs SGFY Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SGFY's P/E ratio is 70.91. In terms of profitability, AUGX's ROE is -1.55%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, AUGX is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
AUGX vs HQY Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while HQY trades at $97.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas HQY's P/E ratio is 23.06. In terms of profitability, AUGX's ROE is -1.55%, compared to HQY's ROE of +0.11%. Regarding short-term risk, AUGX is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
AUGX vs HNGE Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while HNGE trades at $87.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas HNGE's P/E ratio is 44.66. In terms of profitability, AUGX's ROE is -1.55%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, AUGX is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
AUGX vs RCM Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas RCM's P/E ratio is -102.21. In terms of profitability, AUGX's ROE is -1.55%, compared to RCM's ROE of +0.00%. Regarding short-term risk, AUGX is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
AUGX vs TXG Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, TXG has a market cap of 5.6B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while TXG trades at $43.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas TXG's P/E ratio is -257.29. In terms of profitability, AUGX's ROE is -1.55%, compared to TXG's ROE of -0.03%. Regarding short-term risk, AUGX is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
AUGX vs DOCS Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, DOCS has a market cap of 4B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while DOCS trades at $21.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas DOCS's P/E ratio is 14.07. In terms of profitability, AUGX's ROE is -1.55%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, AUGX is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
AUGX vs ONEM Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas ONEM's P/E ratio is -7.77. In terms of profitability, AUGX's ROE is -1.55%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, AUGX is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
AUGX vs PRVA Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while PRVA trades at $26.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas PRVA's P/E ratio is 168.13. In terms of profitability, AUGX's ROE is -1.55%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, AUGX is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
AUGX vs PGNY Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while PGNY trades at $31.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas PGNY's P/E ratio is 23.31. In terms of profitability, AUGX's ROE is -1.55%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, AUGX is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
AUGX vs HTFL Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while HTFL trades at $24.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas HTFL's P/E ratio is -12.92. In terms of profitability, AUGX's ROE is -1.55%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, AUGX is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
AUGX vs WGS Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while WGS trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas WGS's P/E ratio is 74.68. In terms of profitability, AUGX's ROE is -1.55%, compared to WGS's ROE of -0.28%. Regarding short-term risk, AUGX is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
AUGX vs TDOC Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while TDOC trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas TDOC's P/E ratio is -10.47. In terms of profitability, AUGX's ROE is -1.55%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, AUGX is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
AUGX vs NXGN Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas NXGN's P/E ratio is -266.00. In terms of profitability, AUGX's ROE is -1.55%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, AUGX is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
AUGX vs OMDA Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while OMDA trades at $23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas OMDA's P/E ratio is 338.57. In terms of profitability, AUGX's ROE is -1.55%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, AUGX is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
AUGX vs AGTI Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas AGTI's P/E ratio is -71.79. In terms of profitability, AUGX's ROE is -1.55%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, AUGX is less volatile compared to AGTI. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
AUGX vs GDRX Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while GDRX trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas GDRX's P/E ratio is 9.52. In terms of profitability, AUGX's ROE is -1.55%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, AUGX is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
AUGX vs CERT Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CERT trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CERT's P/E ratio is 17.77. In terms of profitability, AUGX's ROE is -1.55%, compared to CERT's ROE of -0.01%. Regarding short-term risk, AUGX is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
AUGX vs CCLDO Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CCLDO's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, AUGX is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
AUGX vs HSTM Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, HSTM has a market cap of 845.5M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while HSTM trades at $28.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas HSTM's P/E ratio is 38.08. In terms of profitability, AUGX's ROE is -1.55%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, AUGX is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check HSTM's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
AUGX vs WGSWW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, WGSWW has a market cap of 748M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, AUGX's ROE is -1.55%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, AUGX is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check WGSWW's competition here
Phreesia, Inc. (NYSE: PHR)
AUGX vs PHR Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, PHR has a market cap of 662M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while PHR trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas PHR's P/E ratio is 38.25. In terms of profitability, AUGX's ROE is -1.55%, compared to PHR's ROE of +0.03%. Regarding short-term risk, AUGX is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check PHR's competition here
Evolent Health, Inc. (NYSE: EVH)
AUGX vs EVH Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, EVH has a market cap of 652.4M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while EVH trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas EVH's P/E ratio is 580.00. In terms of profitability, AUGX's ROE is -1.55%, compared to EVH's ROE of -0.78%. Regarding short-term risk, AUGX is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check EVH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
AUGX vs MPLN-WT Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, AUGX is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
AUGX vs ACCD Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas ACCD's P/E ratio is -3.08. In terms of profitability, AUGX's ROE is -1.55%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, AUGX is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
AUGX vs SHCR Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SHCR's P/E ratio is -3.76. In terms of profitability, AUGX's ROE is -1.55%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, AUGX is less volatile compared to SHCR. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check SHCR's competition here
Claritev Corporation (NYSE: CTEV)
AUGX vs CTEV Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CTEV has a market cap of 517.5M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CTEV trades at $30.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CTEV's P/E ratio is -2.33. In terms of profitability, AUGX's ROE is -1.55%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, AUGX is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
AUGX vs NRC Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, NRC has a market cap of 490.8M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while NRC trades at $21.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas NRC's P/E ratio is 26.56. In terms of profitability, AUGX's ROE is -1.55%, compared to NRC's ROE of +0.57%. Regarding short-term risk, AUGX is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
AUGX vs SOPH Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SOPH trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SOPH's P/E ratio is -11.29. In terms of profitability, AUGX's ROE is -1.55%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, AUGX is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
AUGX vs SLGC Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SLGC's P/E ratio is -3.04. In terms of profitability, AUGX's ROE is -1.55%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, AUGX is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
AUGX vs SLGCW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, AUGX's ROE is -1.55%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, AUGX is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
AUGX vs TBRG Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas TBRG's P/E ratio is 9.37. In terms of profitability, AUGX's ROE is -1.55%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, AUGX is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
AUGX vs MPLN Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas MPLN's P/E ratio is -0.23. In terms of profitability, AUGX's ROE is -1.55%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, AUGX is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
AUGX vs SLP Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SLP's P/E ratio is 20.72. In terms of profitability, AUGX's ROE is -1.55%, compared to SLP's ROE of +0.06%. Regarding short-term risk, AUGX is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
AUGX vs TRHC Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas TRHC's P/E ratio is -4.27. In terms of profitability, AUGX's ROE is -1.55%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, AUGX is less volatile compared to TRHC. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
AUGX vs SMFR Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SMFR's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, AUGX is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
AUGX vs SPOK Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SPOK has a market cap of 222.2M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SPOK trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SPOK's P/E ratio is 17.73. In terms of profitability, AUGX's ROE is -1.55%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, AUGX is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
AUGX vs SY Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SY trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SY's P/E ratio is -5.09. In terms of profitability, AUGX's ROE is -1.55%, compared to SY's ROE of -0.16%. Regarding short-term risk, AUGX is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check SY's competition here
American Well Corporation (NYSE: AMWL)
AUGX vs AMWL Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, AMWL has a market cap of 220.3M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while AMWL trades at $13.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas AMWL's P/E ratio is -2.54. In terms of profitability, AUGX's ROE is -1.55%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, AUGX is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
AUGX vs HCAT Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, HCAT has a market cap of 166.3M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while HCAT trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas HCAT's P/E ratio is 11.25. In terms of profitability, AUGX's ROE is -1.55%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, AUGX is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
AUGX vs CPSI Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CPSI's P/E ratio is -183.80. In terms of profitability, AUGX's ROE is -1.55%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, AUGX is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
AUGX vs OPRX Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, OPRX has a market cap of 125.5M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while OPRX trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas OPRX's P/E ratio is 6.14. In terms of profitability, AUGX's ROE is -1.55%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, AUGX is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check OPRX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
AUGX vs CCLD Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CCLD has a market cap of 98.6M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CCLD trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CCLD's P/E ratio is 8.59. In terms of profitability, AUGX's ROE is -1.55%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, AUGX is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
AUGX vs DH Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, DH has a market cap of 80.1M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while DH trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas DH's P/E ratio is 2.92. In terms of profitability, AUGX's ROE is -1.55%, compared to DH's ROE of -0.67%. Regarding short-term risk, AUGX is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
AUGX vs FORA Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas FORA's P/E ratio is -24.11. In terms of profitability, AUGX's ROE is -1.55%, compared to FORA's ROE of -0.17%. Regarding short-term risk, AUGX is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
AUGX vs CCLDP Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CCLDP's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, AUGX is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
AUGX vs ONMD Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, ONMD has a market cap of 38.7M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while ONMD trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas ONMD's P/E ratio is -4.53. In terms of profitability, AUGX's ROE is -1.55%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, AUGX is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
AUGX vs SNCE Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SNCE's P/E ratio is -0.27. In terms of profitability, AUGX's ROE is -1.55%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, AUGX is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
AUGX vs AKLI Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas AKLI's P/E ratio is -0.71. In terms of profitability, AUGX's ROE is -1.55%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, AUGX is less volatile compared to AKLI. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
AUGX vs SHLT Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SHLT's P/E ratio is -3.87. In terms of profitability, AUGX's ROE is -1.55%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, AUGX is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
AUGX vs SHCRW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, AUGX's ROE is -1.55%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, AUGX is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
AUGX vs ONMDW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas ONMDW's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, AUGX is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
AUGX vs STRM Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas STRM's P/E ratio is -2.40. In terms of profitability, AUGX's ROE is -1.55%, compared to STRM's ROE of -0.32%. Regarding short-term risk, AUGX is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
AUGX vs RNLX Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas RNLX's P/E ratio is -0.33. In terms of profitability, AUGX's ROE is -1.55%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, AUGX is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
AUGX vs LIFW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas LIFW's P/E ratio is -0.02. In terms of profitability, AUGX's ROE is -1.55%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, AUGX is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check LIFW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
AUGX vs EUDA Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, EUDA has a market cap of 21.1M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while EUDA trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas EUDA's P/E ratio is -21.32. In terms of profitability, AUGX's ROE is -1.55%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, AUGX is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check EUDA's competition here
Babylon Holdings Limited (NYSE: BBLN)
AUGX vs BBLN Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas BBLN's P/E ratio is -0.04. In terms of profitability, AUGX's ROE is -1.55%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, AUGX is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
AUGX vs BEATW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, BEATW has a market cap of 13.4M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas BEATW's P/E ratio is -0.04. In terms of profitability, AUGX's ROE is -1.55%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, AUGX is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
AUGX vs ETAO Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas ETAO's P/E ratio is -0.01. In terms of profitability, AUGX's ROE is -1.55%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, AUGX is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
AUGX vs BFRG Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while BFRG trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas BFRG's P/E ratio is -1.20. In terms of profitability, AUGX's ROE is -1.55%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, AUGX is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
AUGX vs HLTH Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas HLTH's P/E ratio is -0.02. In terms of profitability, AUGX's ROE is -1.55%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, AUGX is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
AUGX vs SCNX Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas SCNX's P/E ratio is -0.16. In terms of profitability, AUGX's ROE is -1.55%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, AUGX is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
AUGX vs UPH Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas UPH's P/E ratio is -0.07. In terms of profitability, AUGX's ROE is -1.55%, compared to UPH's ROE of -1.05%. Regarding short-term risk, AUGX is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
AUGX vs UPH-WT Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, AUGX is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
AUGX vs MGRX Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, MGRX has a market cap of 4.2M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while MGRX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas MGRX's P/E ratio is -0.31. In terms of profitability, AUGX's ROE is -1.55%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, AUGX is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
AUGX vs PEAR Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas PEAR's P/E ratio is -0.08. In terms of profitability, AUGX's ROE is -1.55%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, AUGX is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
AUGX vs PEARW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas PEARW's P/E ratio is -0.00. In terms of profitability, AUGX's ROE is -1.55%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, AUGX is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
AUGX vs OTRK Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas OTRK's P/E ratio is -0.02. In terms of profitability, AUGX's ROE is -1.55%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, AUGX is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
AUGX vs VSEEW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, AUGX's ROE is -1.55%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, AUGX is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
AUGX vs HCTI Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, HCTI has a market cap of 2.1M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while HCTI trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas HCTI's P/E ratio is -0.23. In terms of profitability, AUGX's ROE is -1.55%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, AUGX is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
AUGX vs CMAX Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CMAX's P/E ratio is -0.00. In terms of profitability, AUGX's ROE is -1.55%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, AUGX is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
AUGX vs VSEE Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, VSEE has a market cap of 1.6M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while VSEE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas VSEE's P/E ratio is -0.19. In terms of profitability, AUGX's ROE is -1.55%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, AUGX is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
AUGX vs ACON Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while ACON trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas ACON's P/E ratio is -0.24. In terms of profitability, AUGX's ROE is -1.55%, compared to ACON's ROE of -0.54%. Regarding short-term risk, AUGX is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
AUGX vs LIFWZ Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, AUGX is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
AUGX vs EUDAW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, AUGX's ROE is -1.55%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, AUGX is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
AUGX vs WORX Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, WORX has a market cap of 693.4K. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while WORX trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas WORX's P/E ratio is -0.76. In terms of profitability, AUGX's ROE is -1.55%, compared to WORX's ROE of -0.65%. Regarding short-term risk, AUGX is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
AUGX vs MSPRZ Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, AUGX is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
AUGX vs KERN Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas KERN's P/E ratio is -0.01. In terms of profitability, AUGX's ROE is -1.55%, compared to KERN's ROE of -0.17%. Regarding short-term risk, AUGX is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
AUGX vs KERNW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas KERNW's P/E ratio is -0.00. In terms of profitability, AUGX's ROE is -1.55%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, AUGX is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
AUGX vs LIFWW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas LIFWW's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, AUGX is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
AUGX vs ZCMD Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, ZCMD has a market cap of 58K. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while ZCMD trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, AUGX's ROE is -1.55%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, AUGX is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
AUGX vs CMAXW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CMAXW's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, AUGX is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
AUGX vs ACONW Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, ACONW has a market cap of 11.7K. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas ACONW's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, AUGX is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
AUGX vs MTBCO Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas MTBCO's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, AUGX is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
AUGX vs MSPRV Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas MSPRV's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to MSPRV's ROE of N/A. Regarding short-term risk, AUGX is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
AUGX vs MTBCP Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas MTBCP's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, AUGX is less volatile compared to MTBCP. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
AUGX vs MTBC Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas MTBC's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, AUGX is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
AUGX vs CHNG Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CHNG's P/E ratio is -152.72. In terms of profitability, AUGX's ROE is -1.55%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, AUGX is less volatile compared to CHNG. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
AUGX vs CHNGU Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CHNGU's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, AUGX is less volatile compared to CHNGU. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
AUGX vs CNVY Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CNVY's P/E ratio is -71.50. In terms of profitability, AUGX's ROE is -1.55%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, AUGX is less volatile compared to CNVY. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
AUGX vs NAVA Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas NAVA's P/E ratio is N/A. In terms of profitability, AUGX's ROE is -1.55%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, AUGX is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for AUGX.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
AUGX vs CERN Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CERN has a market cap of 0. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CERN's P/E ratio is 55.84. In terms of profitability, AUGX's ROE is -1.55%, compared to CERN's ROE of +0.14%. Regarding short-term risk, AUGX is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for AUGX.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
AUGX vs CSLT Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas CSLT's P/E ratio is -37.27. In terms of profitability, AUGX's ROE is -1.55%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, AUGX is less volatile compared to CSLT. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
AUGX vs NH Comparison July 2026
Augmedix, Inc. (NASDAQ: AUGX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AUGX stands at 115.9M. In comparison, NH has a market cap of 0. Regarding current trading prices, AUGX is priced at $2.35 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AUGX currently has a P/E ratio of -4.99, whereas NH's P/E ratio is -0.12. In terms of profitability, AUGX's ROE is -1.55%, compared to NH's ROE of +0.35%. Regarding short-term risk, AUGX is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for AUGX.Check NH's competition here